Thyrocare Technologies has informed that the Board, at its meeting held today, October 31, 2023, considered and approved the unaudited financial results (standalone and consolidated) for the quarter and half year ended September 30, 2023. Pursuant to Regulation 33(3) of the SEBI Listing Regulations, copies of the standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2023, along with the Limited Review Reports on said financial results issued by the Statutory Auditors of the Company are attached. The said financial results are also being made available on the Company's website at www.thyrocare.com and the extract is being published in one English and one Marathi newspaper.
The above information is a part of company’s filings submitted to BSE.
